Randox Liquid Assayed Specific Protein Control - Level 3 (SP Control 3), Cat. no. PS2684
FDA device recall Z-2280-2018 · posted 2018-06-13 · Terminated
Recall details
- Recalling firm
- Randox Laboratories Ltd.
- Reason for recall
- The recalling firm has confirmed that Free Kappa light chains in Liquid Assayed Specific Protein Controls increase over the shelf life of the product. This may lead to a delay in reporting Free Kappa Light Chains results, which are used as an aid in diagnosis of monoclonal gammopathy of undetermined significance and for Multiple Myeloma through review of the ratio with free lambda chains.
- Action taken
- On May 22, 2018, Randox issued an Urgent Field Safety Notice to affected distributors along with an Important Notice and updated IFU. The letter advised customers of the product issue. It further instructed distributors to do the following: 1. Discuss the contents of the notice with your Medical Director. 2. Place a copy of the important notice and updated IFU into any remaining stock. 3. Complete and return the vigilance response section of this form to technical.services@randox.com within five working days. If you have any questions after reviewing this information, you may contact the firm at technical.services@randox.com.
- Root cause
- Under Investigation by firm
- Status
- Terminated
- Product code
- JJY
- Distribution
- Distributed to accounts in CA, IN, KS, ME, and WV, and PR. Foreign distribution to Australia, Bangladesh, Belarus, Belgium, Brazil, Cambodia, Canada, Chile, China, Colombia, Cyprus, Denmark, Dutch Car
- Date initiated
- 2018-05-22
- Date posted
- 2018-06-13
- Date terminated
- 2020-11-17
- Location
- Crumlin, North, Ireland
Monitor recalls programmatically
Recalls and clearances share one API, with change alerts when new recalls post.
Related 510(k) clearances
| Record | Firm | Date |
|---|---|---|
| RANDOX ASSAYED SPECIFIC PROTEIN CONTROL (K972608) | Randox Laboratories, Ltd. | 1997-08-04 |